10x Genomics Inc (TXG)
14.14
-0.78
(-5.26%)
USD |
NASDAQ |
Nov 14, 16:00
14.11
-0.02
(-0.18%)
After-Hours: 20:00
10x Genomics Enterprise Value: 1.408B for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 1.408B |
| November 12, 2024 | 1.500B |
| November 11, 2024 | 1.527B |
| November 08, 2024 | 1.495B |
| November 07, 2024 | 1.559B |
| November 06, 2024 | 1.611B |
| November 05, 2024 | 1.701B |
| November 04, 2024 | 1.633B |
| November 01, 2024 | 1.579B |
| October 31, 2024 | 1.542B |
| October 30, 2024 | 1.598B |
| October 29, 2024 | 1.513B |
| October 28, 2024 | 1.522B |
| October 25, 2024 | 1.477B |
| October 24, 2024 | 1.475B |
| October 23, 2024 | 1.430B |
| October 22, 2024 | 1.434B |
| October 21, 2024 | 1.462B |
| October 18, 2024 | 1.471B |
| October 17, 2024 | 1.400B |
| October 16, 2024 | 1.507B |
| October 15, 2024 | 1.528B |
| October 14, 2024 | 1.571B |
| October 11, 2024 | 1.570B |
| October 10, 2024 | 1.499B |
| Date | Value |
|---|---|
| October 09, 2024 | 2.121B |
| October 08, 2024 | 2.036B |
| October 07, 2024 | 2.002B |
| October 04, 2024 | 2.025B |
| October 03, 2024 | 1.975B |
| October 02, 2024 | 2.038B |
| October 01, 2024 | 2.181B |
| September 30, 2024 | 2.335B |
| September 27, 2024 | 2.351B |
| September 26, 2024 | 2.307B |
| September 25, 2024 | 2.180B |
| September 24, 2024 | 2.388B |
| September 23, 2024 | 2.296B |
| September 20, 2024 | 2.353B |
| September 19, 2024 | 2.449B |
| September 18, 2024 | 2.280B |
| September 17, 2024 | 2.200B |
| September 16, 2024 | 2.213B |
| September 13, 2024 | 2.315B |
| September 12, 2024 | 2.337B |
| September 11, 2024 | 2.283B |
| September 10, 2024 | 2.230B |
| September 09, 2024 | 2.249B |
| September 06, 2024 | 2.215B |
| September 05, 2024 | 2.408B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.400B
Minimum
Oct 17 2024
21.50B
Maximum
Jun 23 2021
8.410B
Average
5.926B
Median
Jun 02 2023
Enterprise Value Benchmarks
| Omnicell Inc | 2.200B |
| American Shared Hospital Services | 29.34M |
| Astrana Health Inc | 1.895B |
| Cryo-Cell International Inc | 82.53M |
| P3 Health Partners Inc | 299.28M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -35.75M |
| Revenue (Quarterly) | 151.65M |
| Total Expenses (Quarterly) | 193.14M |
| EPS Diluted (Quarterly) | -0.30 |
| Gross Profit Margin (Quarterly) | 70.16% |
| Profit Margin (Quarterly) | -23.58% |
| Earnings Yield | -10.82% |
| Normalized Earnings Yield | -9.901 |